Logo image of BHM

BLUEROCK HOMES TRUST INC (BHM) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:BHM - US09631H1005 - REIT

9.6 USD
-0.2 (-2.04%)
Last: 1/14/2026, 8:14:24 PM
9.69 USD
+0.09 (+0.94%)
After Hours: 1/14/2026, 8:14:24 PM
Fundamental Rating

2

Overall BHM gets a fundamental rating of 2 out of 10. We evaluated BHM against 20 industry peers in the Residential REITs industry. Both the profitability and financial health of BHM have multiple concerns. BHM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year BHM has reported negative net income.
  • BHM had a positive operating cash flow in the past year.
  • BHM had negative earnings in 4 of the past 5 years.
  • Each year in the past 5 years BHM had a positive operating cash flow.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • The Return On Assets of BHM (-0.67%) is worse than 75.00% of its industry peers.
  • With a Return On Equity value of -2.49%, BHM is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.67%
ROE -2.49%
ROIC N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • With a Gross Margin value of 42.91%, BHM is not doing good in the industry: 95.00% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BHM has declined.
  • BHM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 200 -200 400 600

More info and screens

3

2. Health

2.1 Basic Checks

  • BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BHM has been increased compared to 1 year ago.
  • Compared to 1 year ago, BHM has a worse debt to assets ratio.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BHM has an Altman-Z score of 0.19. This is a bad value and indicates that BHM is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BHM (0.19) is worse than 75.00% of its industry peers.
  • BHM has a Debt/Equity ratio of 1.27. This is a high value indicating a heavy dependency on external financing.
  • BHM has a worse Debt to Equity ratio (1.27) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 0.19
ROIC/WACCN/A
WACC4.95%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • BHM has a Current Ratio of 4.66. This indicates that BHM is financially healthy and has no problem in meeting its short term obligations.
  • BHM has a Current ratio of 4.66. This is amongst the best in the industry. BHM outperforms 100.00% of its industry peers.
  • A Quick Ratio of 4.66 indicates that BHM has no problem at all paying its short term obligations.
  • BHM has a Quick ratio of 4.66. This is amongst the best in the industry. BHM outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 4.66
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M

More info and screens

3

3. Growth

3.1 Past

  • BHM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.85%.
  • BHM shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.58%.
  • Measured over the past years, BHM shows a very strong growth in Revenue. The Revenue has been growing by 50.84% on average per year.
EPS 1Y (TTM)-23.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.48%
Revenue 1Y (TTM)34.58%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%34.17%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • BHM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • BHM's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. BHM is more expensive than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.14
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60 -60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

  • BHM has a Yearly Dividend Yield of 7.35%, which is a nice return.
  • Compared to an average industry Dividend Yield of 32.52, BHM pays a better dividend. On top of this BHM pays more dividend than 85.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.35%

5.2 History

  • BHM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BHM Yearly Dividends per shareBHM Yearly Dividends per shareYearly Dividends per share 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BHM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-113.13%
EPS Next 2YN/A
EPS Next 3YN/A
BHM Yearly Income VS Free CF VS DividendBHM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 100M -100M -200M

More info and screens

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (1/14/2026, 8:14:24 PM)

After market: 9.69 +0.09 (+0.94%)

9.6

-0.2 (-2.04%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners34.7%
Inst Owner ChangeN/A
Ins Owners9.18%
Ins Owner Change0%
Market Cap38.98M
Revenue(TTM)59.73M
Net Income(TTM)-6.59M
Analysts84
Price Target11.22 (16.88%)
Short Float %0.45%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 7.35%
Yearly Dividend1.87
Dividend Growth(5Y)N/A
DP-113.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-26.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF 1.81
P/B 0.15
P/tB 0.15
EV/EBITDA 38.14
EPS(TTM)-1.7
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-69.58
FCFYN/A
OCF(TTM)5.3
OCFY55.16%
SpS14.71
BVpS65.24
TBVpS65.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.67%
ROE -2.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.91%
FCFM N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
F-Score6
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 51.35
Cap/Depr 1086.64%
Cap/Sales 508.94%
Interest Coverage N/A
Cash Conversion 327.01%
Profit Quality N/A
Current Ratio 4.66
Quick Ratio 4.66
Altman-Z 0.19
F-Score6
WACC4.95%
ROIC/WACCN/A
Cap/Depr(3y)728.9%
Cap/Depr(5y)962.54%
Cap/Sales(3y)349.98%
Cap/Sales(5y)565.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.58%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%34.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-377.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1128.63%
OCF growth 3Y-2.62%
OCF growth 5YN/A

BLUEROCK HOMES TRUST INC / BHM FAQ

Can you provide the ChartMill fundamental rating for BLUEROCK HOMES TRUST INC?

ChartMill assigns a fundamental rating of 2 / 10 to BHM.


Can you provide the valuation status for BLUEROCK HOMES TRUST INC?

ChartMill assigns a valuation rating of 0 / 10 to BLUEROCK HOMES TRUST INC (BHM). This can be considered as Overvalued.


How profitable is BLUEROCK HOMES TRUST INC (BHM) stock?

BLUEROCK HOMES TRUST INC (BHM) has a profitability rating of 1 / 10.


Can you provide the financial health for BHM stock?

The financial health rating of BLUEROCK HOMES TRUST INC (BHM) is 3 / 10.